IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site
Go back to IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site| (NASDAQ: ICCM) | Delayed: 1.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.08 | 52 Week High | $ | |||
| Open | $1.08 | 52 Week Low | $ | |||
| Day High | $1.08 | P/E | N/A | |||
| Day Low | $1.08 | EPS | $ | |||
| Volume | 445 | |||||



